1.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000446089, P30CA022453, WSU-C-2597, NCT00244933
|
|
2.
|
Phase: Phase II Type: Treatment Status: Completed Age: 21 and over Sponsor: NCI, Other Protocol IDs: CDR0000495776, P30CA022453, WSU-2005-006, WSU-025806MP4F, NCT00376948
|
|
3.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: P2BV10, NCT00546039
|
|
4.
|
Phase: Phase II Type: Prevention Status: Closed Age: 25 and older Sponsor: NCI, Other Protocol IDs: NCI 04B3, NWU03-1-04, NU-NWU03-1-04, NU-NCI-04B3, NU-0835-030, NCT00290758
|
|
5.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000433520, P30CA014520, WCCC-CO-04307, WCCC-UWI03-1-01, WCCC-H-2005-0026, NCT00118040
|
|
6.
|
Phase: Phase I Type: Prevention, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-98-C-0099B
|
|
7.
|
Phase: Phase I Type: Prevention Status: Completed Age: 45 to 70 Sponsor: NCI Protocol IDs: UNC-GCRC-2107, NCT00099008
|
|
8.
|
Phase: No phase specified Type: Treatment Status: Completed Age: Not specified Sponsor: Other Protocol IDs: 200412146, NCT00269555
|
|
9.
|
Phase: No phase specified Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: NU 04V1, CHIR-NU-04V1, NU-IRB-0310-083, NCT00276835
|